Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease
Top Cited Papers
- 1 January 2002
- journal article
- letter
- Published by Springer Nature in Nature
- Vol. 415 (6871) , 536-541
- https://doi.org/10.1038/415536a
Abstract
Activation of naive CD4+ T-helper cells results in the development of at least two distinct effector populations, Th1 and Th2 cells1,2,3. Th1 cells produce cytokines (interferon (IFN)-γ, interleukin (IL)-2, tumour-necrosis factor (TNF)-α and lymphotoxin) that are commonly associated with cell-mediated immune responses against intracellular pathogens, delayed-type hypersensitivity reactions4, and induction of organ-specific autoimmune diseases5. Th2 cells produce cytokines (IL-4, IL-10 and IL-13) that are crucial for control of extracellular helminthic infections and promote atopic and allergic diseases4. Although much is known about the functions of these two subsets of T-helper cells, there are few known surface molecules that distinguish between them6. We report here the identification and characterization of a transmembrane protein, Tim-3, which contains an immunoglobulin and a mucin-like domain and is expressed on differentiated Th1 cells. In vivo administration of antibody to Tim-3 enhances the clinical and pathological severity of experimental autoimmune encephalomyelitis (EAE), a Th1-dependent autoimmune disease, and increases the number and activation level of macrophages. Tim-3 may have an important role in the induction of autoimmune diseases by regulating macrophage activation and/or function.Keywords
This publication has 24 references indexed in Scilit:
- Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression?Springer Seminars in Immunopathology, 1999
- The expanding universe of T-cell subsets: Th1, Th2 and morePublished by Elsevier ,1999
- Functional diversity of helper T lymphocytesNature, 1996
- Bothanti-CD11a(LFA-l) and anti-CD11b (MAC-1) therapy delay the onset and diminish the severity of experimental autoimmune encephalomyelitisJournal of Neuroimmunology, 1995
- An altered peptide ligand mediates immune deviation and prevents autoimmune encephalomyelitisImmunity, 1995
- B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: Application to autoimmune disease therapyCell, 1995
- Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseasesImmunology Today, 1995
- Regulation of Immunity to Parasites by T Cells and T Cell-Derived CytokinesAnnual Review of Immunology, 1992
- Molecular cloning of the CD2 antigen, the T-cell erythrocyte receptor, by a rapid immunoselection procedure.Proceedings of the National Academy of Sciences, 1987
- Continuous cultures of fused cells secreting antibody of predefined specificityNature, 1975